Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis / Sands, Be1; Peyrin-Biroulet, L1; Loftus EV, Jr1; Danese, S1; Colombel, Jf1; Törüner, M1; Jonaitis, L1; Abhyankar, B1; Chen, J1; Rogers, R1; Lirio, Ra1; Bornstein, Jd1; Schreiber, S1; Calvo, S; Gimenez, E; Resk, Jh; Tron, Ep; Al-Ansari, M; Andrews, J; Bampton, P; Debinski, H; Hendy, P; Holtmann, G; Leong, R; Moore, G; Hindryckx, P; Barac, T; Draganova, R; Kotzev, I; Marinova, I; Markov, M; Mihaylov, Y; Pavlov, D; Penkova, M; Petrov, A; Spassova, Z; Stoyanova, D; Velev, E; Vladimirov, B; Yanev, F; Axler, J; Fedorak, R; Fowler, S Jr; Halder, S; Jairath, V; Ponich, T; Wong, K; Baez, E; Ricardo, J; Velasquez, M; Banic, M; Bogadi, I; Borzan, V; Zgrablic, Jc; Duvnjak, M; Gusej, M; Krznaric, Z; Cechova, I; Hala, T; Janu, L; Kohout, P; Lukas, M; Machkova, M; Matous, J; Ulbrych, J; Vanasek, T; Klinge, L; Rannem, T; Theede, K; Borissova, J; Kull, K; Amil, M; Bouhnik, Y; Gilleta, C; Fumery, M; Grimaud, Jc; Hebuterne, X; Laharie, D; Moreau, J; Peyrin-Biroulet, L; Roblin, X; Baumgart, D; Buening, C; Dinter, J; Gauss, A; Kuehbacher, T; Fareed Rahman, K; Schiefke, I; Schreiber, S; Von Amim, U; Zeuzem, S; Leung, Wk; Kin Kong Li, M; Altorjay, I; Bene, L; Lakatos, P; Molnar, T; Salamon, A; Schnabel, R; Tulassay, Z; Avni, Y; Barkay, O; Fishman, S; Goldin, E; Keret, D; Lahat-Zok, A; Melzer, E; Naftali, T; Nimer, A; Ovadia, B; Zittan, E; Andriulli, A; Cappello, M; Castiglione, F; Danese, S; Fries, W; Gionchetti, P; Kohn, A; Maconi, G; Santino, M; Savarino, E; Privitera, A; Romano, M; Vecchi, M; Villa, E; Cheon, Jh; Han, Ds; Jang, Bi; Jeen, Yt; Kim, Js; Kim, Sk; Kim, Hj; Kim, Y; Lee, Km; Lee, Bi; Park, Di; Park, Ys; Song, Ga; Ye, Bd; Pokrotnieks, J; Tolmanis, I; Denapiene, G; Kancauskas, A; Jakovlevaite, V; Jonaitis, L; Cruz Palacios, A; Larriva de Los Reyes, E; Asela Lujano Nicolas, L; Mendoza Fuerte, E; D'Haens, G; Pierik, M; Van Der Woude, J; Adrych, K; Danilkiewicz, Wc; Gawdis-Wojnarska, B; Hartleb, M; Karczewski, M; Kierkus, J; Malecka-Panas, E; Petryka, R; Piotrowski, W; Regula, J; Romatowski, J; Rozciecha, J; Rydzewska, G; Smolinski, P; Walczak, P; Walczak, M; Wozniak-Stolarska, B; Cotter, J; Lopes, L; Portela, F; Rodrigues Carvalho, J; Simona Gheorghe, L; Goldis, Ae; Mateescu, Rb; Abdulkhakov, R; Agafyina, A; Alexeeva, O; Alikhanov, B; Bunkova, E; Dvorkin, M; Gubonina, I; Kashnikov, V; Livzan, M; Osipenko, M; Parfenov, A; Pershko, A; Pesegova, M; Rafalskiy, V; Reshetko, O; Simanenkov, V; Tsybulko, S; Valuyskikh, E; Yakovlev, A; Cvetkovic, M; Damjanov, D; Djuranovic, S; Dugalic, P; Nagorni, A; Svorcan, P; Zdravkovic Petrovic, N; Bunganic, I; Gregus, M; Hlavaty, T; Horvath, F; Domenech Morral, E; Jover Martinez, R; Mendoza, Miv; Shieh, Mj; Wei, Cc; Altintas, E; Atug, O; Gonen, C; Hamzaoglu, H; Hulagu, S; Toruner, M; Chopey, I; Danyliuk, S; Datsenko, O; Golovchenko, N; Golovchenko, O; Hospodarskyy, I; Ivanov, V; Klymenko, V; Levchenko, O; Lizogub, V; Mostovoy, Y; Oliinyk, O; Polianskyi, I; Pyrohovskyi, V; Shevchuk, S; Ursol, G; Vdovychenko, V; Vyshyvanyuk, V; Beales, I; Brookes, M; Nwokolo, C; Winter, J; Aggarwal, A; Aguilar, H; Alnoah, Z; Arce-Nunez, E; Arimie, C; Arterburn, J; Baum, C; Bellaguarda, E; Bock, B; Boone, T; Callahan, N; Chapman, J; Chen, S; Chiorean, M; Coates, A; Connor, M; Dellon, S; Dryden, G; Du Vall, G; Flores, L; Fogel, R; Frias, J; Ginsburg, P; Greenberg, E; Grunkemeier, D; Hellstern, P; Herfarth, H; Hoffman, B; Horst, S; Idarraga, S; Iskandar, H; Jain, R; Jenkins, E; Kaufman, B; Khaleq, A; Khan, A; Khurana, S; Lake, J; Leavitt, J; Leman, B; Lewis, D; Lindenberg, D; Loftus, Ev; Korman, L; Martin, J; Mccullough, M; Mcnair, A; Mehta, N; Mutlu, E; Narayen, V; Paoli-Bruno, J; Perez, N; Phillips, R; Raijman, I; Ramirez-Vega, R; Randall, C; Rinesmith, S; Ritter, T; Safdi, A; Saltzman, M; Sands, B; Seminerio, J; Schulman, M; Sedghi, S; Shafran, I; Shankar, M; Silvers, D; Soloman, N; Tatum, H; Tepper, R; Tiongco, F; Valdes, M; Weber, J; Zhang, C.. - In: THE NEW ENGLAND JOURNAL OF MEDICINE. - ISSN 0028-4793. - (2019).
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
Castiglione FMembro del Collaboration Group
;Khan A;
2019
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.